Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome

Background: In breast cancer (BC), axillary lymph node (ALN) involvement is one of the strongest adverse prognostic factors. However, it is unclear whether loco-regional lymph node deposits are effectively the root of secondary metastases or only an indicator of competence of the primary tumour to s...

Full description

Bibliographic Details
Main Authors: David Venet, Danai Fimereli, Françoise Rothé, Bram Boeckx, Marion Maetens, Samira Majjaj, Ghizlane Rouas, Maria Capra, Giuseppina Bonizzi, Federica Contaldo, Christine Galant, Martine Piccart, Giancarlo Pruneri, Denis Larsimont, Diether Lambrechts, Christine Desmedt, Christos Sotiriou
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420301687
id doaj-485f54bda6f3493aa15d1c17955dc341
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author David Venet
Danai Fimereli
Françoise Rothé
Bram Boeckx
Marion Maetens
Samira Majjaj
Ghizlane Rouas
Maria Capra
Giuseppina Bonizzi
Federica Contaldo
Christine Galant
Martine Piccart
Giancarlo Pruneri
Denis Larsimont
Diether Lambrechts
Christine Desmedt
Christos Sotiriou
spellingShingle David Venet
Danai Fimereli
Françoise Rothé
Bram Boeckx
Marion Maetens
Samira Majjaj
Ghizlane Rouas
Maria Capra
Giuseppina Bonizzi
Federica Contaldo
Christine Galant
Martine Piccart
Giancarlo Pruneri
Denis Larsimont
Diether Lambrechts
Christine Desmedt
Christos Sotiriou
Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
EBioMedicine
Breast cancer
Metastatic dissemination
Axillary lymph node
Distant metastasis
author_facet David Venet
Danai Fimereli
Françoise Rothé
Bram Boeckx
Marion Maetens
Samira Majjaj
Ghizlane Rouas
Maria Capra
Giuseppina Bonizzi
Federica Contaldo
Christine Galant
Martine Piccart
Giancarlo Pruneri
Denis Larsimont
Diether Lambrechts
Christine Desmedt
Christos Sotiriou
author_sort David Venet
title Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
title_short Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
title_full Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
title_fullStr Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
title_full_unstemmed Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
title_sort phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2020-06-01
description Background: In breast cancer (BC), axillary lymph node (ALN) involvement is one of the strongest adverse prognostic factors. However, it is unclear whether loco-regional lymph node deposits are effectively the root of secondary metastases or only an indicator of competence of the primary tumour to spread to distant organs. Methods: Here, we investigated the evolutionary trajectories of primary tumour, ALN and distant metastasis samples from 16 estrogen-receptor (ER)-positive lymph node-positive BC patients. Low-pass whole genome sequencing was performed to infer somatic copy number aberrations and the phylogenetic profiles for all patients were obtained. Findings: We show that lymph nodes and distant metastases shared a common origin in only 25% of the cases highlighting that the predominant route of metastatic dissemination is the direct seeding of tumour cells from the primary tumour to distant organs, independently of lymph node metastasis. Noticeably, patients sharing a common origin significantly have worse prognosis. Interpretation: Our results shed light on the routes on which tumour cells metastasize and their role in disease progression in ER-positive BC. Funding: This work has received financial support from Les Amis de l'Institut Bordet, MEDIC, the Breast Cancer Research Foundation (BCRF), the Belgian Fonds National de la Recherche Scientifique (F.R.S-FNRS) and from a grant of the Région Wallonne.
topic Breast cancer
Metastatic dissemination
Axillary lymph node
Distant metastasis
url http://www.sciencedirect.com/science/article/pii/S2352396420301687
work_keys_str_mv AT davidvenet phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT danaifimereli phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT francoiserothe phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT bramboeckx phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT marionmaetens phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT samiramajjaj phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT ghizlanerouas phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT mariacapra phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT giuseppinabonizzi phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT federicacontaldo phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT christinegalant phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT martinepiccart phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT giancarlopruneri phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT denislarsimont phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT dietherlambrechts phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT christinedesmedt phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
AT christossotiriou phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome
_version_ 1724682673161502720
spelling doaj-485f54bda6f3493aa15d1c17955dc3412020-11-25T03:04:09ZengElsevierEBioMedicine2352-39642020-06-0156102793Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcomeDavid Venet0Danai Fimereli1Françoise Rothé2Bram Boeckx3Marion Maetens4Samira Majjaj5Ghizlane Rouas6Maria Capra7Giuseppina Bonizzi8Federica Contaldo9Christine Galant10Martine Piccart11Giancarlo Pruneri12Denis Larsimont13Diether Lambrechts14Christine Desmedt15Christos Sotiriou16J.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumLaboratory of Translational Genetics, VIB Center for Cancer Biology, Campus Gasthuisberg, O&N IV Herestraat 49 - box 912, 3000, Leuven, Belgium; Laboratory of Translational Genetics, Department of Human Genetics, Katholieke Universiteit Leuven, O&N IV Herestraat 49 - box 912, 3000, Leuven, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, Belgium; Laboratory for Translational Breast Cancer Research, Department of Oncology, Katholieke Universiteit Leuven, O&N I Herestraat 49 - box 818, 3000, Leuven, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumBiobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, ItalyBiobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, ItalyBiobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, ItalyDepartment of Pathology, Cliniques Universitaires Saint Luc, Avenue Hippocrate 10, 1200, Brussels, BelgiumMedical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumBiobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy; Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133, Milan, Italy; School of Medicine, University of Milan, via Festa del Perdono 7, 20122, Milano, Milan, ItalyDepartment of Pathology, Institut Jules Bordet, Bld de Waterloo 121, 1000, Brussels, BelgiumLaboratory of Translational Genetics, VIB Center for Cancer Biology, Campus Gasthuisberg, O&N IV Herestraat 49 - box 912, 3000, Leuven, Belgium; Laboratory of Translational Genetics, Department of Human Genetics, Katholieke Universiteit Leuven, O&N IV Herestraat 49 - box 912, 3000, Leuven, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, Belgium; Laboratory for Translational Breast Cancer Research, Department of Oncology, Katholieke Universiteit Leuven, O&N I Herestraat 49 - box 818, 3000, Leuven, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, Belgium; Corresponding author.Background: In breast cancer (BC), axillary lymph node (ALN) involvement is one of the strongest adverse prognostic factors. However, it is unclear whether loco-regional lymph node deposits are effectively the root of secondary metastases or only an indicator of competence of the primary tumour to spread to distant organs. Methods: Here, we investigated the evolutionary trajectories of primary tumour, ALN and distant metastasis samples from 16 estrogen-receptor (ER)-positive lymph node-positive BC patients. Low-pass whole genome sequencing was performed to infer somatic copy number aberrations and the phylogenetic profiles for all patients were obtained. Findings: We show that lymph nodes and distant metastases shared a common origin in only 25% of the cases highlighting that the predominant route of metastatic dissemination is the direct seeding of tumour cells from the primary tumour to distant organs, independently of lymph node metastasis. Noticeably, patients sharing a common origin significantly have worse prognosis. Interpretation: Our results shed light on the routes on which tumour cells metastasize and their role in disease progression in ER-positive BC. Funding: This work has received financial support from Les Amis de l'Institut Bordet, MEDIC, the Breast Cancer Research Foundation (BCRF), the Belgian Fonds National de la Recherche Scientifique (F.R.S-FNRS) and from a grant of the Région Wallonne.http://www.sciencedirect.com/science/article/pii/S2352396420301687Breast cancerMetastatic disseminationAxillary lymph nodeDistant metastasis